TP53 and neoplasm: From the TCGA cohort of 404 tumour samples (across 23 cancer types) with genome-wide chromatin accessibility data (ATAC-seq) [16], we identified 33 samples harbouring gain-of-function missense mutations (or hotspot mutations) in the DNA-binding domain of p53 (Additional file 1 Table S1).